MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis
- PMID: 27538595
- DOI: 10.1016/j.jns.2016.06.046
MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis
Abstract
Introduction: Skeletal muscle microRNAs (miRNAs) are potential candidate biomarkers for amyotrophic lateral sclerosis (ALS) that deserve further investigation.
Objectives: To identify miRNAs abnormally expressed in the skeletal muscle and plasma of patients with ALS, and to correlate them with parameters of disease progression.
Methods: Expression profile of miRNAs in muscle was evaluated using an array platform. Subsequently we assessed the plasmatic expression of candidate miRNAs in a set of 39 patients/39 controls. We employed generalized estimating equations to investigate correlations with clinical data.
Results: We identified 11 miRNAs differentially expressed in the muscle of ALS patients; of these, miR424, miR-214 and miR-206 were validated by qPCR in muscle samples. In plasma, we found only miR-424 and miR 206 to be overexpressed. Baseline expression of miR-424 and 206 correlated with clinical deterioration over time.
Conclusion: MiR-424 and miR-206 are potential prognostic markers for ALS.
Keywords: Amyotrophic lateral sclerosis; MicroRNA; Motor neuron; Prognosis; Skeletal muscle.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).Neurobiol Aging. 2017 Jul;55:123-131. doi: 10.1016/j.neurobiolaging.2017.03.027. Epub 2017 Apr 1. Neurobiol Aging. 2017. PMID: 28454844 Free PMC article.
-
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.Brain. 2013 Aug;136(Pt 8):2359-68. doi: 10.1093/brain/awt164. Epub 2013 Jul 3. Brain. 2013. PMID: 23824486
-
Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.Muscle Nerve. 2018 Aug;58(2):261-269. doi: 10.1002/mus.26106. Epub 2018 Mar 25. Muscle Nerve. 2018. PMID: 29466830 Free PMC article.
-
Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes.Biomolecules. 2024 Mar 20;14(3):377. doi: 10.3390/biom14030377. Biomolecules. 2024. PMID: 38540795 Free PMC article. Review.
-
Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2018 May 22;19(5):1534. doi: 10.3390/ijms19051534. Int J Mol Sci. 2018. PMID: 29786645 Free PMC article. Review.
Cited by
-
miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis.Hum Mol Genet. 2023 Mar 6;32(6):934-947. doi: 10.1093/hmg/ddac250. Hum Mol Genet. 2023. PMID: 36219176 Free PMC article.
-
An Overview of MicroRNAs as Biomarkers of ALS.Front Neurol. 2019 Mar 7;10:186. doi: 10.3389/fneur.2019.00186. eCollection 2019. Front Neurol. 2019. PMID: 30899244 Free PMC article. Review.
-
Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2020 Mar 3;21(5):1714. doi: 10.3390/ijms21051714. Int J Mol Sci. 2020. PMID: 32138249 Free PMC article. Review.
-
A Machine Learning Approach for Highlighting microRNAs as Biomarkers Linked to Amyotrophic Lateral Sclerosis Diagnosis and Progression.Biomolecules. 2023 Dec 29;14(1):47. doi: 10.3390/biom14010047. Biomolecules. 2023. PMID: 38254647 Free PMC article.
-
Opportunities Offered by Graphene Nanoparticles for MicroRNAs Delivery for Amyotrophic Lateral Sclerosis Treatment.Materials (Basel). 2021 Dec 24;15(1):126. doi: 10.3390/ma15010126. Materials (Basel). 2021. PMID: 35009270 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous